Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2007
11/06/2007US7291491 Polypeptides
11/06/2007US7291490 Nucleic acid fragment encoding an NRPS for the biosynthesis of anthramycin
11/06/2007US7291489 Microorganisms and processes for enhanced production of pantothenate
11/06/2007US7291488 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
11/06/2007US7291483 FGF-CX polynucleotide sequences and methods of producing same
11/06/2007US7291471 Cleavable oligonucleotide arrays
11/06/2007US7291470 Incubating a sample with primers in a PCR reaction solution which amplifies nucleic acids to produce a 369 base pair amplification product, detecting the presence of a 369 base pair amplification product; cutting amplification product by restriction enzyme BstEII;detecting the DNA fragments
11/06/2007US7291469 Mutant met and uses therefor
11/06/2007US7291464 Autocatalysis/yeast two-hybrid assay
11/06/2007US7291463 Incubating/condensating pseudoisocytidine molecule with (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to provide a pseudouridine molecule; oncology diagnosis
11/06/2007US7291461 Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
11/06/2007US7291457 Electrochemical detection of mismatch nucleic acids
11/06/2007US7291455 Detecting cancer in humans; obtain sample, measure viral expression in sample, compare to control, amplified levels of viral expression indicates cancer
11/06/2007US7291329 Antibodies against PRO4406
11/06/2007US7291325 Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins
11/06/2007CA2246346C Method and compounds for inhibition of ribonucleases
11/06/2007CA2159614C Control of plant abscission and pod dehiscence
11/06/2007CA2158486C Coamplification of target nucleic acids using volume exclusion agent, in reaction composition, test kit and test device useful therefor
11/06/2007CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
11/06/2007CA2079879C Nucleotidic sequences coding for alpha chain variable regions in human lymphocite receptors and applications thereof
11/01/2007WO2007124133A2 Methods and compositions based on shiga toxin type 1 protein
11/01/2007WO2007124072A2 Methods for capture and detection of micro-rna molecules from the skin by non-invasive tape stripping
11/01/2007WO2007095976A3 Adjuvant in the form of a lipid-modified nucleic acid
11/01/2007WO2007067946A3 Diagnosis and treatment of chronic lymphocytic leukemia (cll)
11/01/2007WO2007056723A3 Detection of nucleic acids by target-specific hybrid capture method
11/01/2007WO2007033023A3 Compositions and methods for the diagnosis and therapy of bcl2-associated cancers
11/01/2007WO2007010528A3 Methods and kits for identifying nucleic acid sequences
11/01/2007WO2007008712A8 Anti-alpha v beta 6 antibodies and uses thereof
11/01/2007WO2007005955A3 Anti-il-23 antibodies, compositions, methods and uses
11/01/2007WO2007001962A3 Systems and methods for generating biological material
11/01/2007WO2006132669A3 Detection using primers to repetitive dna and transcription-based amplification thereby
11/01/2007WO2006115570A3 Small nucleic acid detection probes and uses thereof
11/01/2007WO2006050414A3 Antisense antiviral compounds and methods for treating filovirus infection
11/01/2007WO2005121330A3 Isolated chimeric proteins of modified lumazine synthase
11/01/2007US20070256198 Delayed Flowering Time Gene (DLF1) in Maize and Uses Thereof
11/01/2007US20070256194 Isolated nucleic acids encoding resistance polypeptides and uses thereof
11/01/2007US20070256150 Method of Producing Double Low Restorer Lines of Brassica Napus Having a Good Agronomic Value
11/01/2007US20070256149 Dep2 and its uses in major depressive disorder and other related disorders
11/01/2007US20070256148 DEP2 and its uses in major depressive disorder and other related disorders
11/01/2007US20070256147 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins
11/01/2007US20070256146 Pufa polyketide synthase systems and uses thereof
11/01/2007US20070256145 Mammalian transforming growth factor beta-9
11/01/2007US20070255054 Oligonucleotide synthesis with intermittent and post synthetic oxidation
11/01/2007US20070255053 Random-primed reverse transcriptase - in vitro transcription method for rna amplification
11/01/2007US20070255052 siRNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC)
11/01/2007US20070255051 efficient sequence specific gene silencing; gene expression inhibition; increases siRNA efficacy
11/01/2007US20070255050 siRNA targeting minichromosome maintenance deficient 2, mitotin (MCM2)
11/01/2007US20070255049 siRNA targeting EPH receptor A3 (EPHA3)
11/01/2007US20070255048 siRNA targeting discoidin domain receptor family, member 1 (DDR1)
11/01/2007US20070255047 siRNA targeting cell division cycle 6 homolog (CDC6)
11/01/2007US20070255046 siRNA targeting spectrin SH3 domain binding protein 1 (SSH3BP1)
11/01/2007US20070255045 O-acetyl-ADP ribose, a histone deacetylase-reaction product, used for producing polyclonal or monoclonal antibodies, and for analysis by competitive binding assaying of aging resistance and/or anticarcinogenic agents
11/01/2007US20070254852 for treatment of cancer
11/01/2007US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007US20070254838 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
11/01/2007US20070254362 COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX
11/01/2007US20070254360 Expression vector comprising nucleotide sequences coding dorsal-ventral patterning fusion protein for use as tool in enhancement of immune response in infected cells
11/01/2007US20070254339 Tetramerizing polypeptides and methods of use
11/01/2007US20070254338 Method for making recombinant protein using complementation dependent DHFR mutants
11/01/2007US20070254336 Transcription Factors
11/01/2007US20070254334 Prokaryotic host cells for expressing proteins rich in disulfide bonds
11/01/2007US20070254329 Mammalian Genes Involved in Viral Infection and Tumor Suppression
11/01/2007US20070254316 Peptides for targeting the prostate specific membrane antigen
11/01/2007US20070254302 Compositions and methods for the diagnosis and treatment of tumor
11/01/2007US20070254299 Fungal delta 12 desaturase and delta 15 desaturase motifs
11/01/2007US20070254298 Atropisomers of asymmetric xanthene fluorescent dyes and method of dna sequencing and fragment analysis
11/01/2007US20070254294 Method for Storing Dna by Using Chitosan, and Products Using the Methods
11/01/2007US20070254292 Method for Trapping Nucleic Acids Using Divalent Metal Ions
11/01/2007US20070254289 Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
11/01/2007US20070254283 Brhf1 as a Cancer Diagnostic Marker
11/01/2007US20070254278 Photocurable Perfluoropolyethers for Use as Novel Materials in Microfluidic Devices
11/01/2007US20070253982 Compositions that include hemagglutinin, methods of making and methods of use thereof
11/01/2007US20070253981 Canine influenza virus
11/01/2007US20070253977 Recombinant respiratory syncytial virus (RSV) strains deleted of the region of G protein most likely to induce unwanted type 2 T cell responses in susceptible recipients; engineered using reverse genetics with deletions of amino acids 151-221 and 178-219; for immunogenic compositions against RSV
11/01/2007US20070253976 Compositions and methods comprising KLK3 of FOLH1 antigen
11/01/2007US20070253974 Elicits the production of antibodies that interfere with invasion by Babesia bovis into erythrocytes, diagnosis
11/01/2007US20070253973 Fusion proteins comprising alpha fetoprotein
11/01/2007US20070253972 For expressing foreign genetic information, e.g. foreign genes, for many applications, including immunogenic or pharmaceutical compositions for pathogens other than mumps, gene therapy, and cell targeting
11/01/2007US20070253971 Circovirus sequences associated with piglet weight loss disease (PWD)
11/01/2007US20070253966 Fusion Proteins
11/01/2007US20070253964 Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
11/01/2007US20070253963 Epithelial cell specific growth factor keratinocyte growth factor (KGF)
11/01/2007US20070253962 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto
11/01/2007US20070253958 Human monoclonal antibodies to FC gamma receptor II (CD32)
11/01/2007US20070253955 Methods for altering fertility
11/01/2007US20070253954 Epha4 As Therapeutic Target Of Prc And Pdaca
11/01/2007US20070253951 Humanized c-Kit antibody
11/01/2007US20070253945 lysozyme produced from a Chalaropsis species of fungi, having a corrected amino acid sequence so as to allow recombinant production of this enzyme with a higher activity; antibacterial agent in applications wherein killing of highly resistant bacteria such as methicillin-resistant is desired
11/01/2007US20070253936 Self-complementary parvoviral vectors, and methods for making and using the same
11/01/2007US20070253935 Surface expression method of peptides p5 and anal3 using the gene encoding poly-gamma-glutamate synthetase
11/01/2007US20070253933 Carotene Synthase Gene and Uses Therefor
11/01/2007US20070253900 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/01/2007CA2649920A1 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
11/01/2007CA2649770A1 Mutated acvr1 for diagnosis and treatment of fibrodyplasia ossificans progressiva (fop)
10/2007
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849802A2 Methods for altering fertility
10/31/2007EP1849800A2 Moraxella catarrhalis proteins
10/31/2007EP1848730A1 Phosphoramidute activator for oligonucleotide synthesis
10/31/2007EP1848672A2 Libraries and methods for isolating antibodies
10/31/2007EP1697534A4 Nucleic acid molecules containing recombination sites and methods of using the same
1 ... 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 ... 899